Precision Molecular Docking & High-Throughput Virtual Screening Services
Accelerate hit discovery with our precision-focused molecular docking and high-throughput virtual screening platform. Dawn of Bioinformatics Ltd. combines structure-based computational techniques with optimized screening pipelines to rapidly evaluate large compound libraries against target biomolecules.
Our in-silico workflows provide detailed insights into binding interactions, affinity ranking, and structural compatibility enabling efficient filtering of candidate molecules and reducing experimental workload. This approach enhances hit identification accuracy and supports informed decision-making in early-stage drug discovery.
Overview
Dawn of Bioinformatics Ltd. delivers precision-driven molecular docking and high-throughput virtual screening (HTVS) solutions to identify and prioritize potential drug candidates with high accuracy. Our DawniLab experts employ advanced computational algorithms and validated scoring functions to predict protein–ligand binding modes, affinities, and interaction profiles. By integrating robust docking workflows with large-scale virtual screening, we enable efficient exploration of extensive chemical spaces and reliable identification of high-potential hits for downstream analysis.
Key Features
• Accurate protein–ligand docking with advanced scoring functions.
• Binding pose prediction and interaction analysis.
• Active site identification and grid-based docking setup.
• Post-docking analysis and target prioritization.
• Visualization of binding interactions with publication-ready outputs.
• Powered by industry-standard platforms (AutoDock Vina, Schrödinger Glide, GOLD, BIOVIA Discovery Studio)